Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is 63.19% vs 23.35% in Sep 2025
Consolidate Net Profit
YoY Growth in quarter ended Sep 2026 is 105.59% vs 66.71% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is 96.45% vs 29.01% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is 5.28% vs 4.80% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025
Compare Quarterly Results Of Kwality Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 11.62% vs 3.34% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 63.19% vs 23.35% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is 13.31% vs 1.26% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 105.59% vs 66.71% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 21.43% vs 5.83% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 96.45% vs 29.01% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 12.41% vs -7.96% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 5.28% vs 4.80% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025